REQUEST A DEMO
Total
USD $0.00
Search more companies

Murli Krishna Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Murli Krishna Pharma Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Murli Krishna Pharma Private Limited is an unlisted company, incorporated on 02/04/2004. It has its registered office in the State of PN, India. Company's corporate identification number (CIN) is U24230PN2004PTC206917 and registration number is 206917. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
D-98, Ranjangaon Midc, Tal Shirur,
Pune; Maharashtra; Postal Code: 412209

Contact Details: Purchase the Murli Krishna Pharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Murli Krishna Pharma Private Limited report to view the information.
Outstanding Shares:
Purchase the Murli Krishna Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Murli Krishna Pharma Private Limited report to view the information.
Incorporation Date:
April 02, 2004
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Nominee Director
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
10.77%
Purchase this report to view the information.
3.83%
Purchase this report to view the information.
2.24%
Company Performance
Financial values in the chart are available after Murli Krishna Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
60.47%
Total operating revenue
58.85%
Operating profit (EBIT)
566.37%
EBITDA
129.01%
Net Profit (Loss) for the Period
336.09%
Total assets
5.92%
Total equity
3.95%
Operating Profit Margin (ROS)
2.32%
Net Profit Margin
1.16%
Return on Equity (ROE)
2.89%
Debt to Equity Ratio
9.51%
Quick Ratio
0.08%
Cash Ratio
0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?